Cytrx reported 1.53M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Brainstorm Cell Therapeutics BCLI:US $ 5.28M 844K
Celldex Therapeutics CLDX:US $ 20.98M 4.06M
Curis CRIS:US $ 13.09M 151K
Cytrx CYTR:US 1.53M 351.4K
Glaxosmithkline GSK:US 7.14B 722M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Karyopharm Therapeutics KPTI:US $ 81.5M 9.85M
Northwest Biotherapeutics NWBO:US 10.4M 2.56M
Novartis NVS:US 10.13B 319M
Seattle Genetics SGEN:US $ 722.02M 243.94M
Takeda 4502:JP 747.39B 46.34B